Idioma:

A prospective evaluation of plasma polyphenol levels and colon cancer risk

Murphy, Neil ; Achaintre, David ; Zamora‐Ros, Raul ; Jenab, Mazda ; Boutron‐Ruault, Marie‐Christine ; Carbonnel, Franck ; Savoye, Isabelle ; Kaaks, Rudolf ; Kühn, Tilman ; Boeing, Heiner ; Aleksandrova, Krasimira ; Tjønneland, Anne ; Kyrø, Cecilie ; Overvad, Kim ; Quirós, J. Ramón ; Sánchez, Maria‐Jose ; Altzibar, Jone M. ; María Huerta, José ; Barricarte, Aurelio ; Khaw, Kay‐Tee ; Bradbury, Kathryn E. ; Perez‐Cornago, Aurora ; Trichopoulou, Antonia ; Karakatsani, Anna ; Peppa, Eleni ; Palli, Domenico ; Grioni, Sara ; Tumino, Rosario ; Sacerdote, Carlotta ; Panico, Salvatore ; Bueno‐de‐Mesquita, H. B(as) ; Peeters, Petra H. ; Rutegård, Martin ; Johansson, Ingegerd ; Freisling, Heinz ; Noh, Hwayoung ; Cross, Amanda J. ; Vineis, Paolo ; Tsilidis, Kostas ; Gunter, Marc J. ; Scalbert, Augustin

International journal of cancer, 2018-10, Vol.143 (7), p.1620-1631 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por

Enviar para

Título:
A prospective evaluation of plasma polyphenol levels and colon cancer risk
Autor: Murphy, Neil ; Achaintre, David ; Zamora‐Ros, Raul ; Jenab, Mazda ; Boutron‐Ruault, Marie‐Christine ; Carbonnel, Franck ; Savoye, Isabelle ; Kaaks, Rudolf ; Kühn, Tilman ; Boeing, Heiner ; Aleksandrova, Krasimira ; Tjønneland, Anne ; Kyrø, Cecilie ; Overvad, Kim ; Quirós, J. Ramón ; Sánchez, Maria‐Jose ; Altzibar, Jone M. ; María Huerta, José ; Barricarte, Aurelio ; Khaw, Kay‐Tee ; Bradbury, Kathryn E. ; Perez‐Cornago, Aurora ; Trichopoulou, Antonia ; Karakatsani, Anna ; Peppa, Eleni ; Palli, Domenico ; Grioni, Sara ; Tumino, Rosario ; Sacerdote, Carlotta ; Panico, Salvatore ; Bueno‐de‐Mesquita, H. B(as) ; Peeters, Petra H. ; Rutegård, Martin ; Johansson, Ingegerd ; Freisling, Heinz ; Noh, Hwayoung ; Cross, Amanda J. ; Vineis, Paolo ; Tsilidis, Kostas ; Gunter, Marc J. ; Scalbert, Augustin
Assuntos: Biological activity ; biomarkers ; Biomarkers, Tumor - blood ; Body Mass Index ; Cancer ; Cancer Epidemiology ; Case-Control Studies ; Colon ; Colon cancer ; Colonic Neoplasms - blood ; Colonic Neoplasms - diagnosis ; Colonic Neoplasms - etiology ; Colorectal cancer ; EPIC ; Female ; Follow-Up Studies ; Health risk assessment ; Health risks ; Heterogeneity ; High performance liquid chromatography ; High pressure ; Homovanillic acid ; Humans ; Liquid chromatography ; Male ; Mass spectrometry ; Mass spectroscopy ; Medical research ; Middle Aged ; Multivariable control ; nested case-control study ; Polyphenols ; Polyphenols - blood ; Prognosis ; Prospective Studies ; Regression analysis ; Risk Factors ; Statistical analysis ; Tumorigenesis
É parte de: International journal of cancer, 2018-10, Vol.143 (7), p.1620-1631
Notas: Disclosure of Potential Conflicts of Interest: The authors declare no potential conflicts of interest.
For information on how to submit an application for gaining access to EPIC data and/or biospecimens, please follow the instructions at
http://epic.iarc.fr/access/index.php
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
For information on how to submit an application for gaining access to EPIC data and/or biospecimens, please follow the instructions at http://epic.iarc.fr/access/index.php
Descrição: Polyphenols have been shown to exert biological activity in experimental models of colon cancer; however, human data linking specific polyphenols to colon cancer is limited. We assessed the relationship between pre‐diagnostic plasma polyphenols and colon cancer risk in a case–control study nested within the European Prospective Investigation into Cancer and Nutrition study. Using high pressure liquid chromatography coupled to tandem mass spectrometry, we measured concentrations of 35 polyphenols in plasma from 809 incident colon cancer cases and 809 matched controls. We used multivariable adjusted conditional logistic regression models that included established colon cancer risk factors. The false discovery rate (qvalues) was computed to control for multiple comparisons. All statistical tests were two‐sided. After false discovery rate correction and in continuous log2‐transformed multivariable models, equol (odds ratio [OR] per log2‐value, 0.86, 95% confidence interval [95% CI] = 0.79–0.93; qvalue = 0.01) and homovanillic acid (OR per log2‐value, 1.46, 95% CI = 1.16–1.84; qvalue = 0.02) were associated with colon cancer risk. Comparing extreme fifths, equol concentrations were inversely associated with colon cancer risk (OR = 0.61, 95% CI = 0.41–0.91, ptrend = 0.003), while homovanillic acid concentrations were positively associated with colon cancer development (OR = 1.72, 95% CI = 1.17–2.53, ptrend < 0.0001). No heterogeneity for these associations was observed by sex and across other colon cancer risk factors. The remaining polyphenols were not associated with colon cancer risk. Higher equol concentrations were associated with lower risk, and higher homovanillic acid concentrations were associated with greater risk of colon cancer. These findings support a potential role for specific polyphenols in colon tumorigenesis. What's new? Polyphenols are antioxidants abundant in food, and some polyphenols have demonstrated an anti‐cancer effect. Here, the authors looked for an association between polyphenols and colon cancer risk by conducting a nested case–control analysis within the EPIC cohort. Rather than employing questionnaires that rely on participant memories of their diet, this study directly measured 35 polyphenols in plasma samples and compared them with colon cancer risk. Only 2 chemicals showed any association. Concentrations of equol, which is metabolized from soy foods, were inversely associated with colon cancer risk. Higher levels of homovanillic acid, on the other hand, were associated with increased risk.
Editor: United States: Wiley Subscription Services, Inc
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

A prospective evaluation of plasma polyphenol levels and colon cancer risk

United States: Wiley Subscription Services, Inc

Buscando em bases de dados remotas. Favor aguardar.